What's New in Dietary Supplements
FDA takes numerous actions on dietary supplements to protect public health.
FDA works with industry and our state partners to publish press releases and other public notices about recalls that may potentially present a significant or serious risk to the consumer or user of the product. Not all recalls have press releases or are posted on this page. See additional information on recalls.
FDA issues Warning Letters to let companies know that they have violated the laws we enforce and to tell them what corrective action they need to take. See additional information on warning letters.
April 2024
March 2024
February 2024
November 2022
August 2022
June 2022
May 2022
- FDA Releases Draft Guidance on NDI Enforcement Discretion
- FDA Sends Warning Letters to Multiple Companies for Illegally Selling Adulterated Dietary Supplements
April 2022
March 2022
November 2021
September 2021
May 2021
February 2021
November 2019
April 2019
- FDA Acts on Dietary Supplements Containing DMHA and Phenibut
- FDA Implements New Dietary Supplement Ingredient Advisory List
- FDA Announcing Public Meeting to Discuss Responsible Innovation in Dietary Supplements
February 2019
New Efforts to Strengthen Regulation of Dietary Supplements